Cargando…

Additive Intraocular Pressure-Lowering Effects of Ripasudil with Glaucoma Therapeutic Agents in Rabbits and Monkeys

Ripasudil hydrochloride hydrate (K-115), a specific Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor, is developed for the treatment of glaucoma and ocular hypertension. Topical administration of ripasudil decreases intraocular pressure (IOP) by increasing conventional outflow t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaneko, Yoshio, Ohta, Masayuki, Isobe, Tomoyuki, Nakamura, Yuto, Mizuno, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429944/ https://www.ncbi.nlm.nih.gov/pubmed/28540083 http://dx.doi.org/10.1155/2017/7079645

Ejemplares similares

Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm’s canal endothelial cells
por: Kaneko, Yoshio, et al.
Publicado: (2016)

Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study
por: Futakuchi, Akiko, et al.
Publicado: (2020)

Ripasudil in a Model of Pigmentary Glaucoma
por: Wang, Chao, et al.
Publicado: (2020)

Intraocular pressure-lowering effects of Ripasudil: a potential outcome marker for Trabeculotomy
por: Goda, Erina, et al.
Publicado: (2019)

Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Patients with Glaucoma or Ocular Hypertension over 24 Months
por: Tanihara, Hidenobu, et al.
Publicado: (2022)

Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
por: Tanihara, Hidenobu, et al.
Publicado: (2023)

Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma: Safety, Efficacy, and Patient Selection
por: Kusuhara, Sentaro, et al.
Publicado: (2020)

Role of ripasudil as an adjunct treatment in the management of pseudoexfoliative glaucoma
por: Mohapatra, Sumita, et al.
Publicado: (2023)

Comparison of intraocular pressure-lowering effects of ripasudil hydrochloride hydrate for inflammatory and corticosteroid-induced ocular hypertension
por: Yasuda, Mami, et al.
Publicado: (2017)

Effects of Ripasudil on Open-Angle Glaucoma after Circumferential Suture Trabeculotomy Ab Interno
por: Sato, Tomoki, et al.
Publicado: (2021)

Circadian Fluctuation Changes in Intraocular Pressure Measured Using a Contact Lens Sensor in Patients with Glaucoma after the Adjunctive Administration of Ripasudil: A Prospective Study
por: Huang, Shih-Kung, et al.
Publicado: (2023)

Safety, efficacy, and patient selection of ripasudil in patients with uncontrolled glaucoma with maximum conventional medical therapy
por: Jethva, Jignesh, et al.
Publicado: (2022)

Effect of ripasudil on diabetic macular edema
por: Minami, Yoshiro, et al.
Publicado: (2019)

Responsiveness to ripasudil may be a potential outcome marker for selective laser trabeculoplasty in patients with primary open-angle glaucoma
por: Baba, Taro, et al.
Publicado: (2021)

Favorable effect of ripasudil use on surgical outcomes of microhook ab interno trabeculotomy
por: Okuda, Mina, et al.
Publicado: (2023)

Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine
por: Chihara, Etsuo, et al.
Publicado: (2018)

Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET)
por: Araie, Makoto, et al.
Publicado: (2023)

Topical Ripasudil for the Treatment of Primary Corneal Endothelial Degeneration in Dogs
por: Michalak, Sarah R., et al.
Publicado: (2022)

Intraocular Pressure-Lowering Effects of Trabeculectomy Versus MicroShunt Insertion in Rabbit Eyes
por: Fujimoto, Tomokazu, et al.
Publicado: (2021)

A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
por: Mizuno, Yu, et al.
Publicado: (2023)

Effect of dexmedetomidine on intraocular pressure as an additive in peribulbar block during glaucoma surgery
por: Pegu, Julie, et al.
Publicado: (2021)

EXPERIMENTAL YAWS IN THE MONKEY AND RABBIT
por: Nichols, Henry J.
Publicado: (1910)

Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
por: Tanihara, Hidenobu, et al.
Publicado: (2020)

Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study
por: Tanihara, Hidenobu, et al.
Publicado: (2019)

Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma
por: Naik, Mayuresh, et al.
Publicado: (2021)

Crosslinking-Induced Corneal Endothelium Dysfunction and Its Protection by Topical Ripasudil Treatment
por: Wang, Xuemei, et al.
Publicado: (2022)

Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin
por: McClintock, Michael, et al.
Publicado: (2015)

Additive effects of genetic variants associated with intraocular pressure in primary open-angle glaucoma
por: Mabuchi, Fumihiko, et al.
Publicado: (2017)

Evaluation of monkey intraocular pressure by rebound tonometer
por: Yu, Wenhan, et al.
Publicado: (2009)

Effect of the rho-kinase inhibitor ripasudil in needling with mitomycin C for the failure of filtering bleb after trabeculectomy: a cross-sectional study
por: Mizuno, Yu, et al.
Publicado: (2022)

Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
por: Mizoguchi, Takanori, et al.
Publicado: (2011)

Correction to: Safety and efficacy of ripasudil in Japanese patients with glaucoma or ocular hypertension: 12-month interim analysis of ROCK-J, a post-marketing surveillance study
por: Tanihara, Hidenobu, et al.
Publicado: (2020)

Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival
por: Inomata, Takenori, et al.
Publicado: (2020)

Short-Term Changes in the Photopic Negative Response Following Intraocular Pressure Lowering in Glaucoma
por: Tang, Jessica, et al.
Publicado: (2020)

Δ(9)-Tetrahydrocannabinol Derivative-Loaded Nanoformulation Lowers Intraocular Pressure in Normotensive Rabbits
por: Taskar, Pranjal S., et al.
Publicado: (2019)

Lowering the Intraocular Pressure in Rats and Rabbits by Cordyceps cicadae Extract and Its Active Compounds
por: Lee, Li-Ya, et al.
Publicado: (2022)

Glaucoma Surgery Calculator: Limited Additive Effect of Phacoemulsification on Intraocular Pressure in Ab Interno Trabeculectomy
por: Neiweem, Ashley E., et al.
Publicado: (2016)

Dexmedetomidine as an Additive to Local Anesthesia for Decreasing Intraocular Pressure in Glaucoma Surgery: A Randomized Trial
por: Ali, Hassan, et al.
Publicado: (2020)

Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye‐drops among rats, rabbits and monkeys
por: Horita, Shinya, et al.
Publicado: (2019)

Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits
por: Jain, Neelam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uget7696krpr0nq4rphs7rcakn